Artal Group’s Evelo Biosciences, Inc. Common Stock EVLO Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q1 | – | Sell |
-50,000
| Closed | -$6.07M | – | 152 |
|
|
2021
Q4 | $6.07M | Hold |
50,000
| – | – | 0.16% | 88 |
|
|
2021
Q3 | $7.04M | Hold |
50,000
| – | – | 0.16% | 93 |
|
|
2021
Q2 | $13.7M | Hold |
50,000
| – | – | 0.28% | 69 |
|
|
2021
Q1 | $10.7M | Buy |
50,000
+15,000
| +43% | +$3.21M | 0.19% | 85 |
|
|
2020
Q4 | $8.46M | Buy |
35,000
+11,250
| +47% | +$2.72M | 0.18% | 84 |
|
|
2020
Q3 | $2.5M | Sell |
23,750
-9,583
| -29% | -$1.01M | 0.06% | 105 |
|
|
2020
Q2 | $3.27M | Buy |
+33,333
| New | +$3.27M | 0.09% | 100 |
|